News

Intermezzo (zolpidem tartrate), which contains a bicarbonate-carbonate buffer, is available in spearmint-flavored sublingual tablets that are placed under the tongue and allowed to disintegrate completely before swallowing. The

The agreement is intended for the manufacture and sale of three anti-ageing products specifically formulated by Phosphagenics for the Indian market. Under the deal, Intas will pay an

The delivery method will provide benefits of cannabinoid-based healthcare research to medical professionals and patients looking for innovative products. The product can be formulated in different dosage levels

Karolinska Institutet will use Advaxis immunotherapies to develop allergy treatments using the models that were developed at Karolinska. Advaxis chairman/CEO Thomas Moore said: "The Karolinska Institutet is a

PGen will put in certain know-how and trade secrets including its patented, Elastatropin human based protein, into the collaboration. American CryoStem will contribute certain intellectual property, know-how and

In the multicenter, open-label extension study reported no serious adverse events that were considered drug-related. The most common adverse events that arose during the trial were diarrhea (9.6%),

The randomized, double-blinded, placebo-controlled study met its primary endpoint of a dose-responsive increase in hemoglobin from baseline over the 42 days of the study (p<0.0001). The results show

The filing was based on the Phase III VELOUR study in patients with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen. The companies have also announced the

Mylan alleges Teva did not keep up valid paragraph IV certifications as a result of its purchase of Cephalon and the FDA should have found Mylan as the